|
|
Enrichment of Leishmania donovani ATP-binding proteins using a staurosporine capture compound.
Olivier Leclercq
,
Kathrin Bartho
,
Erik Duelsner
,
Lisa von Kleist
,
Pier Federico Gherardini
,
et al.
Journal articles
pasteur-01433419v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Etablissement d’une approche de déconvolution de cibles pour des composés leishmanicides Ecole Pratique des Hautes Etudes Mémoire préparé sous la direction de Gérald Späth, Najma Rachidi et Sylvie Demignot
Olivier Leclercq
Biochimie [q-bio.BM]. 2016
Master thesis
hal-01468100v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability
Wai-Lok Yau
,
Thierry Blisnick
,
Jean-François Taly
,
Manuela Helmer-Citterich
,
Cordelia Schiene-Fischer
,
et al.
Journal articles
pasteur-01433566v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The Crystal Structure of the MAP Kinase LmaMPK10 from Leishmania Major Reveals Parasite-Specific Features and Regulatory Mechanisms.
Sofía Horjales
,
Dirk Schmidt-Arras
,
Ramiro Rodriguez Limardo
,
Olivier Leclercq
,
Gonzalo Obal
,
et al.
Journal articles
pasteur-00727033v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Transgenic analysis of the Leishmania MAP kinase MPK10 reveals an auto-inhibitory mechanism crucial for stage-regulated activity and parasite viability.
Mathieu Cayla
,
Najma Rachidi
,
Olivier Leclercq
,
Dirk Schmidt-Arras
,
Heidi Rosenqvist
,
et al.
Journal articles
pasteur-01109591v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
From drug screening to target deconvolution: A target-based drug discovery pipeline using Leishmania casein kinase 1 isoform 2 to identify compounds with anti-leishmanial activity
Emilie Durieu
,
Eric Prina
,
Olivier Leclercq
,
Nassima Oumata
,
Nicolas Gaboriaud-Kolar
,
et al.
Journal articles
hal-01299756v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Adaptation of a 2D in-gel kinase assay to trace phosphotransferase activities in the human pathogen Leishmania donovani
Dirk Schmidt-Arras
,
Olivier Leclercq
,
Pier Federico Gherardini
,
Manuela Helmer-Citterich
,
Wolfgang Faigle
,
et al.
Journal articles
pasteur-01433562v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection
Najma Rachidi
,
Jean François Taly
,
Emilie Durieu
,
Olivier Leclercq
,
Nathalie Aulner
,
et al.
Journal articles
pasteur-01433412v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses
Mariko Dacher
,
Miguel A Morales
,
Pascale Pescher
,
Olivier Leclercq
,
Najma Rachidi
,
et al.
Journal articles
hal-01178772v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition
Marc-Antoine Bazin
,
Sandrine Cojean
,
Fabrice Pagniez
,
Guillaume Bernadat
,
Christian Cavé
,
et al.
Journal articles
pasteur-03108849v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ectopic Expression of AID in a Non-B Cell Line Triggers A∶T and G:C Point Mutations in Non-Replicating Episomal Vectors
Tihana Jovanic
,
Benjamin Roche
,
Géraldine Attal-Bonnefoy
,
Olivier Leclercq
,
François Rougeon
Journal articles
hal-04194767v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|